CIK 0001837607
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853940478
- Phone
- +1 949-354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- Open-market buys, last 90 days
- $57,054
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$57,054. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award | +1,316,872 | 2,183,436 | ||
| 2026-02-17 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award | +862,500 | 866,564 | ||
| 2025-05-21 | Oh Chad Chief Medical Officer | Grant or award · Restricted Stock Units | +1,316,872 | 1,316,872 | ||
| 2024-08-31 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award | +192,117 | 292,545 | ||
| 2024-08-31 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +512,673 | 512,673 | ||
| 2024-03-19 | Oh Chad CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +86,720 | 86,720 | ||
| 2023-07-21 | Oh Chad Chief Medical Officer | Grant or award · Stock Option | +145,588 | 145,588 | ||
| 2023-07-21 | Oh Chad Chief Medical Officer | Grant or award · Stock Option | +115,151 | 115,151 | ||
| 2023-07-21 | Oh Chad Chief Medical Officer | Grant or award · Restricted Stock Units | +100,428 | 100,428 |
Page 1 of 1 · 9 trades